Faeth Therapeutics, Inc. (FTH)
38.93
-0.19
(-0.49%)
USD |
NASDAQ |
Sep 03, 13:39
Faeth Therapeutics 1 Year Total Returns (Daily) : 398.3% for Sept. 2, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 02, 2026 | 398.3% |
| September 01, 2026 | 313.0% |
| August 31, 2026 | 292.2% |
| August 28, 2026 | 305.0% |
| August 27, 2026 | 320.7% |
| August 26, 2026 | 320.9% |
| August 25, 2026 | 325.6% |
| August 24, 2026 | 336.1% |
| August 21, 2026 | 324.1% |
| August 20, 2026 | 303.3% |
| August 19, 2026 | 314.9% |
| August 18, 2026 | 299.0% |
| August 17, 2026 | 277.5% |
| August 14, 2026 | 331.2% |
| August 13, 2026 | 277.7% |
| August 12, 2026 | 288.7% |
| August 11, 2026 | 300.5% |
| August 10, 2026 | 273.5% |
| August 07, 2026 | 238.3% |
| August 06, 2026 | 215.9% |
| August 05, 2026 | 198.4% |
| August 04, 2026 | 194.8% |
| August 03, 2026 | 164.8% |
| July 31, 2026 | 264.2% |
| July 30, 2026 | 294.3% |
| Date | Value |
|---|---|
| July 29, 2026 | 325.4% |
| July 28, 2026 | 316.1% |
| July 27, 2026 | 318.9% |
| July 24, 2026 | 295.1% |
| July 23, 2026 | 291.0% |
| July 22, 2026 | 297.5% |
| July 21, 2026 | 268.0% |
| July 20, 2026 | 259.6% |
| July 17, 2026 | 222.6% |
| July 16, 2026 | 216.2% |
| July 15, 2026 | 295.8% |
| July 14, 2026 | 309.6% |
| July 13, 2026 | 308.6% |
| July 10, 2026 | 297.4% |
| July 09, 2026 | 255.6% |
| July 08, 2026 | 210.3% |
| July 07, 2026 | 185.4% |
| July 06, 2026 | 171.2% |
| July 02, 2026 | 147.4% |
| July 01, 2026 | 167.3% |
| June 30, 2026 | 191.4% |
| June 29, 2026 | 167.5% |
| June 26, 2026 | 172.9% |
| June 25, 2026 | 187.0% |
| June 24, 2026 | 189.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Perspective Therapeutics, Inc. | -6.63% |
| Praxis Precision Medicines, Inc. | 695.5% |
| Opus Genetics, Inc. | 261.8% |
| Jade Biosciences, Inc. | 180.8% |
| ACADIA Pharmaceuticals, Inc. | 12.61% |